K

Kleo Pharmaceuticals Inc.

24 employees

Kleo is developing two types of small molecules to treat cancer, infectious diseases, and a broad range of indications

Basic info

Industry

biotechnology

Sectors

Health Care
Medical
Pharmaceutical

Date founded

2015

Funding rounds raised

Total raised

$21M

from 2 investors over 2 rounds

K

Kleo Pharmaceuticals Inc. raised $21M on November 14, 2018

Investors: Biohaven Pharmaceuticals

K

Kleo Pharmaceuticals Inc. raised undisclosed on September 1, 2016

Investors: Biohaven Pharmaceuticals

FAQ